Dojolvi (triheptanoin)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Dojolvi (triheptanoin), covering 2026-04-21 to 2026-04-21. Get the full timeline:
Most recent: Clinical Trial Update: Study of Triheptanoin for the Prevention of Hypoglycemia in Patients With Medium Chain Acyl-CoA Dehydrogenase Deficiency (MCADD) [Phase 2]